UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

             Date of Report (date of earliest event reported): January 11, 2010


                               CEL-SCI CORPORATION
               --------------------------------------------------
             (Exact name of Registrant as specified in its charter)



    Colorado                          0-11503                    84-0916344
---------------------------     -----------------------      -----------------
(State or other jurisdiction    (Commission File No.)          (IRS Employer
of incorporation)                                           Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
  ---------------------------------------------------------------------------
          (Address of principal executive offices, including Zip Code)



             Registrant's telephone number, including area code: (703) 506-9460
                                                                 --------------


                                       N/A
                      -----------------------------------
                (Former name or former address if changed since last report)



<PAGE>


Item 4.02  Non-Reliance on Previously  Issued Financial  Statements or a Related
           Audit Report or Completed Interim Review.

      On January 11, 2009, CEL-SCI's Chief Executive and Financial Officer
determined that there were errors in its 10-Q reports which were filed during
the first three quarters of its 2009 fiscal year. The errors, none of which
affected the Company source or use of cash, are described below:

     o    During the three  months ended  December 31, 2008,  and March 31, 2009
          deferred rent in the amount of $222,527  should have been expensed for
          each period.  However,  CEL-SCI did not expense any deferred  rent for
          the three months ended December 31, 2008 or March 31, 2009 but instead
          expensed  deferred rent of $667,581 during the three months ended June
          30, 2009. CEL-SCI will amend its 10-Q reports to reflect deferred rent
          expense of 222,527 for each of these three-month periods.

     o    A derivative  liability in the amount of  $2,852,666  associated  with
          warrants  issued in connection  with CEL-SCI's June 2009 financing was
          recorded as equity  instead of a  liability.  In  addition,  a loss of
          $101,166  associated  with these warrants should have been expensed at
          June 30, 2009. CEL-SCI will amend its 10-Q report for the three months
          ended June 30, 2009 to correct these errors.

     o    The cost, for financial reporting purposes,  of $455,000 for extending
          the  expiration  date of a  warrant  should  have been  recorded  as a
          dividend and not as an expense. CEL-SCI will amend its 10-Q report for
          the three months ended June 30, 2009 to correct this error.

      CEL-SCI's Chief Executive, Accounting and Financial Officer has discussed
these errors with CEL-SCI's independent accountant.

      The adjustments which will be made to CEL-SCI's 10-Q reports are reflected
in CEL-SCI's financial statements for the year ended September 30, 2009 and are
described in Note 14 to such financial statements. It is expected that these
financial statements will be filed by January 13, 2010 with CEL-SCI's Form 10-K
report.

     CEL-SCI will file amended  10-Q reports as soon as  practicable  to reflect
the correction of these errors.


<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Date:  January 13, 2010

                                 CEL-SCI CORPORATION



                                 By:   /s/ Geert R. Kersten
                                      ----------------------------------------
                                      Geert R. Kersten, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem4021-10.txt", "description": "8-K RE ITEM 4.02", "secsgml_size_bytes": 4417}]
{"company-data": {"conformed-name": "CEL SCI CORP", "cik": "0000725363", "assigned-sic": "2836", "irs-number": "840916344", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11889", "film-number": "10525334"}, "business-address": {"street1": "8229 BOONE BLVD .", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182", "phone": "7035069460"}, "mail-address": {"street1": "8229 BOONE BLVD.", "street2": "SUITE 802", "city": "VIENNA", "state": "VA", "zip": "22182"}, "former-company": {"former-conformed-name": "INTERLEUKIN 2 INC", "date-changed": "19880317"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

             Date of Report (date of earliest event reported): January 11, 2010

                               CEL-SCI CORPORATION
               --------------------------------------------------
             (Exact name of Registrant as specified in its charter)

    Colorado                          0-11503                    84-0916344
---------------------------     -----------------------      -----------------
(State or other jurisdiction    (Commission File No.)          (IRS Employer
of incorporation)                                           Identification No.)

                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
  ---------------------------------------------------------------------------
          (Address of principal executive offices, including Zip Code)

             Registrant's telephone number, including area code: (703) 506-9460
                                                                 --------------

                                       N/A
                      -----------------------------------
                (Former name or former address if changed since last report)
Item 4.02  Non-Reliance on Previously  Issued Financial  Statements or a Related
           Audit Report or Completed Interim Review.

      On January 11, 2009, CEL-SCI's Chief Executive and Financial Officer
determined that there were errors in its 10-Q reports which were filed during
the first three quarters of its 2009 fiscal year. The errors, none of which
affected the Company source or use of cash, are described below:

     o    During the three  months ended  December 31, 2008,  and March 31, 2009
          deferred rent in the amount of $222,527  should have been expensed for
          each period.  However,  CEL-SCI did not expense any deferred  rent for
          the three months ended December 31, 2008 or March 31, 2009 but instead
          expensed  deferred rent of $667,581 during the three months ended June
          30, 2009. CEL-SCI will amend its 10-Q reports to reflect deferred rent
          expense of 222,527 for each of these three-month periods.

     o    A derivative  liability in the amount of  $2,852,666  associated  with
          warrants  issued in connection  with CEL-SCI's June 2009 financing was
          recorded as equity  instead of a  liability.  In  addition,  a loss of
          $101,166  associated  with these warrants should have been expensed at
          June 30, 2009. CEL-SCI will amend its 10-Q report for the three months
          ended June 30, 2009 to correct these errors.

     o    The cost, for financial reporting purposes,  of $455,000 for extending
          the  expiration  date of a  warrant  should  have been  recorded  as a
          dividend and not as an expense. CEL-SCI will amend its 10-Q report for
          the three months ended June 30, 2009 to correct this error.

      CEL-SCI's Chief Executive, Accounting and Financial Officer has discussed
these errors with CEL-SCI's independent accountant.

      The adjustments which will be made to CEL-SCI's 10-Q reports are reflected
in CEL-SCI's financial statements for the year ended September 30, 2009 and are
described in Note 14 to such financial statements. It is expected that these
financial statements will be filed by January 13, 2010 with CEL-SCI's Form 10-K
report.

     CEL-SCI will file amended  10-Q reports as soon as  practicable  to reflect
the correction of these errors.
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  January 13, 2010

                                 CEL-SCI CORPORATION

                                 By:   /s/ Geert R. Kersten
                                      ----------------------------------------
                                      Geert R. Kersten, Chief Executive Officer